“…The sequence of Smg provides no obvious suggestion of how it may act in translational repression as a consequence of binding to the nos 39 UTR+ This is not surprising, as very few translational repressors have been characterized and the only domains whose function is understood are those involved in RNA binding (for examples, see Murata & Wharton, 1995;Dubnau & Struhl, 1996;Rivera-Pomar et al+, 1996;Bashaw & Baker, 1997;Ostareck et al+, 1997;Webster et al+, 1997;Zhang et al+, 1997;Wharton et al+, 1998;Jan et al+, 1999)+ At present, nos is the only known transcript with a recognizable SRE, despite sequence inspection of numerous other maternally expressed genes+ Neverthe-less, there may well be other targets, as the ubiquitous appearance of Smg in early embryos should allow it to act on other mRNAs+ In addition, Smg may also act later in development, when nos mRNA is no longer present+ Although by Western blot analysis we can only detect Smg protein in early embryos, this method might not reveal the expression of Smg in small populations of cells at the later stages+ Indeed, whole-mount antibody stains suggest that the Smg protein appears in the region of the ventral nerve cord as well as the brain during embryogenesis (C+A+ Smibert, Y+S+ Lie, W+ Shillinglaw, W+J+ Henzel, P+M+ Macdonald, unpubl+ data), and a smg EST cDNA clone has been identified in a Drosophila head cDNA library (BDGP; GenBank accession number AI134156)+ Identification of potential target mRNAs, those that contain SRE-like sequences, will soon be possible on a genome-wide scale when sequencing of the genome is complete+…”